Melman S T, Nimeh J W, Anbar R D
MCP Hahnemann School of Medicine, Philadelphia, PA 19107 USA.
Environ Health Perspect. 1998 Oct;106(10):655-7. doi: 10.1289/ehp.106-1533171.
In November 1997, the Centers for Disease Control and Prevention (CDC) released revised guidelines for lead poisoning screening, including a recommendation that states and regions individualize screening policies based on local prevalence of elevated lead levels. The purpose of this study was to collect prevalence data for a Philadelphia, Pennsylvania, inner-city pediatric outpatient population previously not known to have elevated blood lead levels in order to determine its risk for lead exposure and screening requirements. Charts were reviewed for 817 children of 10 months through 6 years of age whose venous blood lead levels were obtained as part of their routine health care over a 12-month period ending October 1992. None of these children had a history of previously elevated lead levels. Prevalence of elevated lead levels was determined for this population and correlated with patient age, sex, race, and insurance type. More than two-thirds (68%) of the study patients had a blood lead level of [Greater than and equal to]10 microg/dl. Elevated blood lead levels were associated with black race (p<0.0001), but not with sex or insurance type. The percentage of children with elevated blood lead levels was highest at ages 37-48 months. A majority of the children screened had lead levels in excess of the CDC threshold for an abnormal lead level (10 microgram/dl). This is the highest reported prevalence within a U.S. pediatric clinic population. In view of this extremely high prevalence, clinicians and public health personnel caring for children in Philadelphia inner-city clinics must follow the intent of the new CDC guidelines by increasing their efforts in the areas of screening, follow-up, and environmental interventions. To ensure a lead-safe upbringing for children in the United States, state health officials nationwide should perform local risk assessments before considering policy transitions from universal to targeted screening.
1997年11月,美国疾病控制与预防中心(CDC)发布了铅中毒筛查的修订指南,其中建议各州和地区根据当地铅水平升高的患病率制定个性化的筛查政策。本研究的目的是收集宾夕法尼亚州费城一个市中心儿科门诊人群的患病率数据,该人群此前未知血铅水平升高,以确定其铅暴露风险和筛查需求。回顾了1992年10月结束的12个月期间,817名10个月至6岁儿童的病历,这些儿童的静脉血铅水平是其常规医疗保健的一部分。这些儿童均无先前血铅水平升高的病史。确定了该人群中铅水平升高的患病率,并与患者的年龄、性别、种族和保险类型相关联。超过三分之二(68%)的研究患者血铅水平≥10微克/分升。血铅水平升高与黑人种族相关(p<0.0001),但与性别或保险类型无关。血铅水平升高的儿童百分比在37至48个月龄时最高。大多数接受筛查的儿童铅水平超过了CDC异常铅水平阈值(10微克/分升)。这是美国儿科诊所人群中报告的最高患病率。鉴于这一极高的患病率,在费城城市中心诊所照顾儿童的临床医生和公共卫生人员必须遵循新的CDC指南的意图,加强在筛查、随访和环境干预方面的工作。为确保美国儿童有一个无铅的成长环境,全国各州卫生官员在考虑从普遍筛查向有针对性筛查的政策转变之前,应进行当地风险评估。